Wilmington Savings Fund Society FSB Cuts Stake in CME Group Inc. $CME

Wilmington Savings Fund Society FSB reduced its stake in CME Group Inc. (NASDAQ:CME) by 0.7% during the second quarter, Holdings Channel.com reports. The institutional investor owned 52,457 shares of the financial services provider’s stock after selling 371 shares during the period. Wilmington Savings Fund Society FSB’s holdings in CME Group were worth $14,458,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Heartland Bank & Trust Co purchased a new position in shares of CME Group in the 1st quarter worth about $377,000. Catalyst Capital Advisors LLC boosted its holdings in shares of CME Group by 256.9% in the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock worth $971,000 after buying an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. purchased a new position in shares of CME Group in the 1st quarter worth about $367,000. Fulcrum Equity Management purchased a new position in shares of CME Group in the 1st quarter worth about $258,000. Finally, AIA Group Ltd boosted its holdings in shares of CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock worth $4,416,000 after buying an additional 2,510 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Trading Down 0.1%

Shares of CME opened at $271.28 on Tuesday. The business’s 50-day moving average price is $268.57 and its 200-day moving average price is $271.35. CME Group Inc. has a twelve month low of $213.94 and a twelve month high of $290.79. The stock has a market cap of $97.76 billion, a PE ratio of 26.26, a P/E/G ratio of 5.72 and a beta of 0.41. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the prior year, the business posted $2.56 earnings per share. The company’s revenue was up 10.4% on a year-over-year basis. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio is currently 48.40%.

Analyst Ratings Changes

A number of equities analysts recently weighed in on CME shares. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday. Barclays lowered their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. JPMorgan Chase & Co. boosted their price objective on CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research note on Thursday, September 25th. Piper Sandler boosted their price objective on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Finally, Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $283.43.

Insider Buying and Selling

In related news, insider Timothy Francis Mccourt sold 379 shares of the company’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,043 shares of company stock valued at $3,527,956. Corporate insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.